A Dark Vector Cognition product

Item 1. Financial Statements

120K characters. Original on sec.gov ·

Item 1. Financial Statements

The 37 tables in Item 1. Financial Statements as one CSV, figures in aligned columns. For subscribers: paste your API key. One API call. Plans from $19 a month, see pricing.

AXON ENTERPRISE, INC.

CONSOLIDATED BALANCE SHEETS

(in thousands, except share data)

September 30, 2026December 31, 2025
(Unaudited)
ASSETS
Current assets:
Cash and cash equivalents$1,458,817$1,201,147
Short-term investments181,587505,417
Marketable securities14,75127,213
Accounts and notes receivable, net of allowance of $4,451 and $4,198 as of September 30, 2026 and December 31, 2025, respectively838,294777,486
Contract assets, net866,856582,630
Inventory579,225341,811
Prepaid expenses201,603149,800
Other current assets141,084127,548
Total current assets4,282,2173,713,052
Property and equipment, net357,342330,979
Deferred tax assets, net333,585359,803
Intangible assets, net268,817196,972
Goodwill1,885,3481,370,189
Long-term notes receivable, net1,7046,066
Long-term contract assets, net298,906178,249
Strategic investments924,934416,833
Other long-term assets479,924428,170
Total assets$8,832,777$7,000,313
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable$249,940$139,086
Accrued liabilities398,475510,538
Current portion of deferred revenue742,247714,708
Current portion of notes payable, net—80,552
Customer deposits17,02016,156
Other current liabilities19,2209,107
Total current liabilities1,426,9021,470,147
Deferred revenue, net of current portion435,326359,902
Liability for unrecognized tax benefits26,51724,376
Long-term deferred compensation34,57323,675
Long-term lease liabilities100,86198,942
Long-term notes payable, net2,868,0371,730,170
Other long-term liabilities177,63350,443
Total liabilities5,069,8493,757,655
Commitments and contingencies (Note 11)
Stockholders’ equity:
Preferred stock, $0.00001 par value; 25,000,000 shares authorized; no shares issued and outstanding as of September 30, 2026 and December 31, 2025, respectively——
Common stock, $0.00001 par value; 200,000,000 shares authorized, 101,686,312 shares issued and 81,411,739 shares outstanding as of September 30, 2026, and 200,000,000 shares authorized, 100,444,971 shares issued and 80,211,537 shares outstanding as of December 31, 202511
Additional paid-in capital2,764,8682,475,035
Treasury stock at cost, 20,274,573 shares and 20,233,434 shares as of September 30, 2026 and December 31, 2025, respectively(180,164)(157,242)
Retained earnings1,192,415936,670
Accumulated other comprehensive loss(14,192)(11,806)
Total stockholders’ equity3,762,9283,242,658
Total liabilities and stockholders’ equity$8,832,777$7,000,313

The accompanying notes are an integral part of these consolidated financial statements.

AXON ENTERPRISE, INC.

CONSOLIDATED STATEMENTS OF OPERATIONS

AND COMPREHENSIVE INCOME

(in thousands, except per share data)

(unaudited)

Three Months Ended September 30,Nine Months Ended September 30,
2026202520262025
Net sales from products$471,524$405,399$1,430,898$1,122,655
Net sales from services437,030305,2421,189,390860,157
Net sales908,554710,6412,620,2881,982,812
Cost of product sales268,629203,173744,646566,861
Cost of service sales124,94780,120336,931219,121
Cost of sales393,576283,2931,081,577785,982
Gross margin514,978427,3481,538,7111,196,830
Operating expenses:
Selling, general and administrative280,496252,803830,571718,524
Research and development192,402176,674590,039490,264
Total operating expenses472,898429,4771,420,6101,208,788
Income (loss) from operations42,080(2,129)118,101(11,958)
Interest income5,65723,94123,08357,798
Interest expense(28,337)(28,912)(85,081)(65,419)
Other income, net59,52022,803255,722104,790
Income before provision for income taxes78,92015,703311,82585,211
Provision for (benefit from) income taxes21,91417,88956,080(36,700)
Net income (loss)$57,006$(2,186)$255,745$121,911
Net income (loss) per common and common equivalent shares:
Basic$0.70$(0.03)$3.17$1.57
Diluted$0.68$(0.03)$3.08$1.48
Weighted average number of common and common equivalent shares outstanding:
Basic81,04478,41680,59277,774
Diluted83,67378,41682,92882,218
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
Net income (loss)$57,006$(2,186)$255,745$121,911
Foreign currency translation adjustments2,261(25)(2,239)5,492
Unrealized gain (loss) on available-for-sale investments(36)213(147)162
Comprehensive income (loss)$59,231$(1,998)$253,359$127,565

The accompanying notes are an integral part of these consolidated financial statements.

AXON ENTERPRISE, INC.

CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY

(in thousands, except share data)

(unaudited)

Common StockAdditional Paid-in CapitalTreasury StockRetained EarningsAccumulated Other Comprehensive LossTotal Stockholders’ Equity
SharesAmountSharesAmount
Balance, December 31, 202580,211,537$1$2,475,03520,233,434$(157,242)$936,670$(11,806)$3,242,658
Issuance of common stock under employee plans, net189,933—(12,169)————(12,169)
Stock-based compensation——134,701————134,701
Issuance of replacement awards in connection with acquisitions——1,345————1,345
Conversion of convertible debt and shares received from convertible note hedge, net170,731—22,97941,139(22,922)——57
Tax effect of redemption and voluntary conversions of convertible debt——(2,327)————(2,327)
Net income—————169,312—169,312
Other comprehensive income, net——————536536
Balance, March 31, 202680,572,201$1$2,619,56420,274,573$(180,164)$1,105,982$(11,270)$3,534,113
Issuance of common stock237,240—100,259————100,259
Issuance of common stock under employee plans, net425,853—(128,331)————(128,331)
Stock-based compensation——143,996————143,996
Other627—220————220
Net income—————29,427—29,427
Other comprehensive loss, net——————(5,147)(5,147)
Balance, June 30, 202681,235,921$1$2,735,70820,274,573$(180,164)$1,135,409$(16,417)$3,674,537
Issuance of common stock under employee plans, net175,818—(26,761)————(26,761)
Stock-based compensation——156,365————156,365
Purchase of capped calls——(114,971)————(114,971)
Other——14,527————14,527
Net income—————57,006—57,006
Other comprehensive income, net——————2,2252,225
Balance, September 30, 202681,411,739$1$2,764,86820,274,573$(180,164)$1,192,415$(14,192)$3,762,928
Common StockAdditional Paid-in CapitalTreasury StockRetained EarningsAccumulated Other Comprehensive LossTotal Stockholders’ Equity
SharesAmountSharesAmount
Balance, December 31, 202476,619,331$1$1,689,78120,220,227$(155,947)$812,014$(18,184)$2,327,665
Issuance of common stock under employee plans, net190,558—(5,035)————(5,035)
Stock-based compensation——140,239————140,239
Induced conversion of convertible debt1,038,259—20,819————20,819
Tax effect of partial repurchase of convertible debt——(16,049)————(16,049)
Net income—————87,980—87,980
Other comprehensive income, net——————234234
Balance, March 31, 202577,848,148$1$1,829,75520,220,227$(155,947)$899,994$(17,950)$2,555,853
Issuance of common stock250,000—183,643————183,643
Issuance of common stock under employee plans, net404,893—(187,800)————(187,800)
Stock-based compensation——139,244————139,244
Tax effect of partial repurchase of convertible debt——111————111
Net income—————36,117—36,117
Other comprehensive income, net——————5,2325,232
Balance, June 30, 202578,503,041$1$1,964,95320,220,227$(155,947)$936,111$(12,718)$2,732,400
Issuance of common stock213,088—178,498————178,498
Issuance of common stock under employee plans, net175,033—(27,305)————(27,305)
Stock-based compensation——146,152————146,152
Conversion of convertible debt and shares received from convertible note hedge, net3—855(5)——3
Net loss—————(2,186)—(2,186)
Other comprehensive income, net——————188188
Balance, September 30, 202578,891,165$1$2,262,30620,220,282$(155,952)$933,925$(12,530)$3,027,750

The accompanying notes are an integral part of these consolidated financial statements.

AXON ENTERPRISE, INC.

CONSOLIDATED STATEMENTS OF CASH FLOWS

(in thousands)

(unaudited)

Nine Months Ended September 30,
20262025
Cash flows from operating activities:
Net income$255,745$121,911
Adjustments to reconcile net income to net cash provided by (used in) operating activities:
Stock-based compensation435,062425,635
Gain on strategic investments and marketable securities, net(257,616)(134,647)
Debt inducement expense—28,584
Depreciation and amortization96,05956,216
Provision for bad debts and inventory7,2088,828
Deferred income taxes36,093(53,696)
Noncash lease expense10,9627,026
Other noncash items27,9138,904
Change in assets and liabilities:
Receivables and contract assets(448,926)(366,053)
Inventory(238,141)(58,177)
Deferred revenue85,22721,556
Accounts payable, accrued and other liabilities108,78644,730
Prepaid expenses and other assets(110,125)(116,713)
Net cash provided by (used in) operating activities8,247(5,896)
Cash flows from investing activities:
Purchases of investments(490,743)(2,045,738)
Business combinations, net of cash acquired(552,018)(22,809)
Proceeds from call, maturity, and sale of investments509,4301,644,556
Purchases of property and equipment(82,762)(74,450)
Other, net(2,201)(49)
Net cash used in investing activities(618,294)(498,490)
Cash flows from financing activities:
Net proceeds from equity offering100,259362,241
Proceeds from issuance of notes1,150,0001,750,000
Purchase of capped calls related to the 2031 convertible senior notes(114,885)—
Principal payments for conversion and redemption of convertible debt(81,110)(407,472)
Income and payroll tax payments for net-settled stock awards(167,156)(209,631)
Payments to third parties for debt issuance, amendments, conversion, redemption and capped call activity(17,311)(26,888)
Other, net671(226)
Net cash provided by financing activities870,4681,468,024
Effect of exchange rate changes on cash and cash equivalents(1,786)5,741
Net change in cash and cash equivalents258,635969,379
Cash and cash equivalents and restricted cash, beginning of period1,213,393466,763
Cash and cash equivalents and restricted cash, end of period$1,472,028$1,436,142
Supplemental disclosures:
Cash and cash equivalents$1,458,817$1,423,871
Restricted cash (Note 1)13,21112,271
Total cash, cash equivalents and restricted cash shown in the statements of cash flows$1,472,028$1,436,142
Cash paid for interest$108,187$56,468
Non-cash transactions:
Leased assets obtained in exchange for new operating lease liabilities$10,634$51,780
Property and equipment purchases in accounts payable and accrued liabilities$4,323$3,432
Expense for induced conversion of convertible debt, debt offering, revolver modifications and capped calls$2,607$31,570
Taxes withheld on stock-based awards included in accrued expenses$105$10,510

The accompanying notes are an integral part of these consolidated financial statements.

Note 1 – Organization and Summary of Significant Accounting Policies

Axon Enterprise, Inc. (“Axon”, the “Company”, “we”, or “us”) is a provider of public safety technology solutions. Our mission is to protect life in service of promoting peace, justice and strong institutions.

The accompanying unaudited consolidated financial statements include the accounts of Axon Enterprise, Inc. and our subsidiaries. All intercompany accounts, transactions and profits have been eliminated.

Basis of Presentation and Use of Estimates

These unaudited consolidated financial statements have been prepared pursuant to the rules and regulations of the SEC. Certain information related to our organization, significant accounting policies and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) has been condensed or omitted. The accounting policies followed in the preparation of these unaudited consolidated financial statements are consistent with those followed in our consolidated financial statements for the year ended December 31, 2025, as filed on our 2025 Annual Report on Form 10-K. In the opinion of management, these unaudited consolidated financial statements contain all material adjustments, consisting only of normal recurring adjustments, necessary to fairly state our financial position, results of operations and cash flows for the periods presented and the presentations and disclosures herein are adequate when read in conjunction with the financial statements included in our 2025 Annual Report on Form 10-K for the year ended December 31, 2025.

Our results of operations for the three and nine months ended September 30, 2026 are not necessarily indicative of the results to be expected for the full year (or any other period). The preparation of the financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues, expenses, and the related disclosures at the date of the financial statements and during the reporting period. We believe the estimates used in the preparation of these unaudited consolidated financial statements are reasonable; however, actual results could differ materially from those estimates.

Certain amounts in prior periods’ consolidated financial statements have been reclassified to conform to current period presentation. These reclassifications are not material and had no effect on the previously reported consolidated financial statements.

Concentration of Credit Risk

Financial instruments that potentially subject us to concentrations of credit risk consist of accounts and notes receivable, contract assets and cash. Historically, we have experienced an immaterial level of write-offs related to uncollectible accounts. We hold the majority of our cash and cash equivalents accounts at three depository institutions. As of September 30, 2026, the aggregate balances in such accounts were $1.2 billion. Our balances with these and other institutions regularly exceed Federal Deposit Insurance Corporation insured limits for domestic deposits and various deposit insurance programs in Australia, Canada, Germany, and the United Kingdom, among others. To manage the related credit exposure, management continually monitors the creditworthiness of the financial institutions where we have deposits.

Segment Information

As described further within our 2025 Annual Report on Form 10-K, we have two reportable segments: Connected Devices and Software and Services. Our chief operating decision maker (“CODM”) is our Chief Executive Officer. The segment measure of profit and loss is adjusted gross margin, as the CODM allocates resources and assesses performance based on review of adjusted gross margin by segment. Assets and other expense items, such as research and development and selling, general, and administrative expenses, are not provided to the CODM by segment, as our CODM does not evaluate our operating segments using this discrete information. For additional details, refer to Note 13.

Restricted Cash

Restricted cash balances were $13.2 million and $12.2 million as of September 30, 2026 and December 31, 2025, respectively. The restricted cash balance at September 30, 2026 includes a $9.7 million payment held in escrow related to the planned construction of our headquarters building in Arizona. Restricted cash also includes funds held in international bank accounts for various operating and financing activities.

Warranty Reserves

We warrant our conducted energy devices (“CEDs”), Axon cameras and other hardware on a limited basis for a period of primarily one year after purchase. Changes in our estimated product warranty liabilities were as follows (in thousands):

Nine Months Ended September 30,
20262025
Balance, beginning of period$10,858$8,284
Utilization of reserve(10,864)(6,757)
Warranty expense10,1889,378
Balance, end of period$10,182$10,905

Income per Common Share

Basic income per common share is computed by dividing net income by the weighted average number of common shares outstanding during the periods presented. Diluted income per share reflects the potential dilution from outstanding stock-based awards, our 2027 Notes, warrants to acquire shares of our common stock (the “Warrants” or “2027 Warrants”), and our 2031 Notes. These items are excluded from the computation of diluted net income per share in periods in which the effect would be antidilutive. For additional information regarding our 2027 Notes, 2027 Warrants, and 2031 Notes, refer to Note 8.

The calculation of the weighted average number of shares outstanding and earnings per share is as follows (in thousands except per share data):

Three Months Ended September 30,Nine Months Ended September 30,
2026202520262025
Numerator for basic and diluted earnings per share:
Net income (loss)$57,006$(2,186)$255,745$121,911
Denominator:
Weighted average shares outstanding81,04478,41680,59277,774
Dilutive effect of stock-based awards1,340—1,3521,846
Dilutive effect of 2027 Notes (1)——311,092
Dilutive effect of 2027 Warrants980—8471,506
Dilutive effect of 2031 Notes (2)309—106—
Diluted weighted average shares outstanding83,67378,41682,92882,218
Net income (loss) per common share:
Basic$0.70$(0.03)$3.17$1.57
Diluted$0.68$(0.03)$3.08$1.48

(1)We redeemed all of our remaining outstanding 2027 Notes during the three months ended March 31, 2026, and we repurchased a portion of the 2027 Notes during the three months ended March 31, 2025. Accordingly, the dilutive impact to the nine months ended September 30, 2026 and September 30, 2025 related to the 2027 Notes is weighted for (a) the number of days between the beginning of the period and the respective closing dates of each transaction, which includes the total amount of shares issuable upon a conversion of all of the 2027 Notes outstanding as of the beginning of the respective periods, and (b) subsequent to the respective closing dates, which includes the amount of shares issuable upon a conversion of the 2027 Notes that remain after each respective transaction. No 2027 Notes remained outstanding following settlement of the aforementioned redemption. Refer to Note 8 for additional details.

(2)The dilutive effect of our 2031 Notes is calculated based upon the most advantageous conversion rate from the standpoint of the holder. Refer to Note 8 for additional details related to the conversion criteria applicable for our 2031 Notes.

Potentially dilutive securities that are not included in the calculation of diluted net income per share because doing so would be antidilutive are as follows (in thousands):

Three Months Ended September 30,Nine Months Ended September 30,
2026202520262025
Stock-based awards3,2565,1383,4413,299
2027 Notes—1,235—401
2027 Warrants1,6823,0171,8151,511
2031 Notes2,566—2,769—
Total potentially dilutive securities7,5049,3908,0255,211

Accounting Guidance and Disclosure Rules - Recently Adopted

In September 2025, the Financial Accounting Standards Board (“FASB”) issued ASU 2025‑06, Intangibles - Goodwill and Other - Internal‑Use Software (Subtopic 350-40): Targeted Improvements to the Accounting for Internal‑Use Software. ASU 2025‑06 is intended to modernize the internal‑use software model primarily by removing software development stages and introducing a “probable-to-complete recognition threshold.” The provisions of ASU 2025-06 are effective for our Annual Report on Form 10-K for the year ending December 31, 2026. We elected to early adopt this ASU in the first quarter of 2026 on a fully prospective basis. The adoption of this standard did not result in any material impacts to our consolidated financial statements.

In July 2025, the FASB issued ASU 2025‑05, Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses for Accounts Receivable and Contract Assets. ASU 2025‑05 is intended to provide a practical expedient for estimating expected credit losses on current trade receivables and current contract assets. The provisions of ASU 2025‑05 are effective for annual periods beginning after December 15, 2025. We adopted this standard in the first quarter of 2026. The adoption of this standard did not result in any material impacts to our consolidated financial statements.

Accounting Guidance and Disclosure Rules - Not Yet Adopted

Refer to Note 1 to the consolidated financial statements in our 2025 Annual Report on Form 10-K for a discussion of applicable standards issued and not yet adopted. Relevant new unadopted standards issued subsequent to our most recent Annual Report are included below.

In May 2026, the FASB issued ASU 2026-02, Environmental Credits and Environmental Credit Obligations (Topic 818). ASU 2026-02 establishes recognition, measurement, presentation, and disclosure requirements for environmental credits and environmental credit obligations. The provisions of ASU 2026-02 are effective for our Quarterly Report on Form 10-Q for the quarter ending March 31, 2028 and subsequent interim and annual periods thereafter, with early adoption permitted. We are currently evaluating the impact of this update on our consolidated financial statements.

Note 2 – Revenues

Nature of Products and Services

The following table presents our revenues by primary product and service offering and reportable segment (in thousands):

Three Months Ended September 30, 2026Three Months Ended September 30, 2025
Connected DevicesSoftware and ServicesTotalConnected DevicesSoftware and ServicesTotal
TASER (1)$233,040$—$233,040$237,950$—$237,950
Personal Sensors (2)113,532—113,532106,677—106,677
Platform Solutions (3)124,952—124,95260,772—60,772
Software and Services—437,030437,030—305,242305,242
Total$471,524$437,030$908,554$405,399$305,242$710,641
Nine Months Ended September 30, 2026Nine Months Ended September 30, 2025
Connected DevicesSoftware and ServicesTotalConnected DevicesSoftware and ServicesTotal
TASER (1)$727,214$—$727,214$649,679$—$649,679
Personal Sensors (2)317,675—317,675287,901—287,901
Platform Solutions (3)386,009—386,009185,075—185,075
Software and Services—1,189,3901,189,390—860,157860,157
Total$1,430,898$1,189,390$2,620,288$1,122,655$860,157$1,982,812

(1)'TASER' includes TASER devices, cartridges and related extended warranties.

(2)'Personal Sensors' primarily includes body cameras and accessories, signal sidearm, and related extended warranties.

(3)'Platform Solutions' primarily includes fleet in-car video, interview room, fixed cameras, drones and counter-drone equipment, virtual reality training hardware, and related extended warranties.

The following table presents our revenues disaggregated by geography (dollars in thousands):

Three Months Ended September 30,Nine Months Ended September 30,
2026202520262025
United States$772,02685%$593,93984%$2,160,86082%$1,660,69584%
Other countries136,52815116,70216459,42818322,11716
Total$908,554100%$710,641100%$2,620,288100%$1,982,812100%

Revenue Recognized from Contract Liabilities

During the nine months ended September 30, 2026 and 2025, we recognized revenue of $676.5 million and $590.3 million, respectively, from our beginning contract liabilities balance as of December 31, 2025 and 2024, respectively. Refer to our consolidated balance sheets for additional details regarding our receivables, contract assets and contract liabilities from contracts with customers.

Remaining Performance Obligations

As of September 30, 2026, we had approximately $10.2 billion of remaining performance obligations, which included both recognized contract liabilities as well as amounts that will be invoiced and recognized in future periods. The remaining performance obligations are limited only to arrangements that meet the definition of a contract under ASC 606 as of September 30, 2026. We currently expect to recognize approximately 20% - 25% of this balance over the next 12 months, and expect the remainder to be substantially recognized over the following ten years, subject to risks related to delayed deployments, budget appropriation or other contract cancellation clauses.

Note 3 – Cash, Cash Equivalents and Investments

The following tables summarize our cash, cash equivalents, marketable securities and available-for-sale debt investments at September 30, 2026 and December 31, 2025 (in thousands):

As of September 30, 2026
Amortized CostGross Unrealized GainsGross Unrealized LossesFair ValueCash and Cash EquivalentsMarketable SecuritiesShort-Term Investments
Cash$160,684$—$—$160,684$160,684$—$—
Level 1:
Money market funds1,057,391——1,057,3911,057,391——
U.S. Treasury bills99,138—(7)99,13150,110—49,021
Marketable securities13,1001,651—14,751—14,751—
Agency bonds400——400——400
Subtotal1,170,0291,651(7)1,171,6731,107,50114,75149,421
Level 2:
Term deposits219,257——219,257143,558—75,699
Corporate bonds88,9819(38)88,95243,355—45,597
Commercial paper10,871—(1)10,870——10,870
Certificates of deposit3,719——3,7193,719——
Subtotal322,8289(39)322,798190,632—132,166
Total$1,653,541$1,660$(46)$1,655,155$1,458,817$14,751$181,587

During the nine months ended September 30, 2026, proceeds from the sale of available-for-sale securities were $70.5 million. As of September 30, 2026, we held $150.4 million of available-for-sale debt investments with unrealized losses, of which none have been in a continuous unrealized loss position for 12 months or longer.

During the nine months ended September 30, 2026, net proceeds from the sales of marketable securities were $3.7 million, representing net realized gains of $1.7 million from the time of purchase. During the three and nine months ended September 30, 2026, we recorded an unrealized loss of $4.4 million and $8.9 million on marketable securities still held as of the reporting date, respectively. We recorded an unrealized gain of $9.3 million and an unrealized loss of $12.9 million on marketable securities, respectively, for the same periods in the prior year.

As of December 31, 2025
Amortized CostGross Unrealized GainsGross Unrealized LossesFair ValueCash and Cash EquivalentsMarketable SecuritiesShort-Term Investments
Cash$168,294$—$—$168,294$168,294$—$—
Level 1:
Money market funds821,711——821,711821,711——
Marketable securities15,09312,120—27,213—27,213—
U.S. Treasury bills231,76669—231,835200,200—31,635
Agency bonds6,4563—6,459——6,459
Subtotal1,075,02612,192—1,087,2181,021,91127,21338,094
Level 2:
Term deposits385,942——385,94210,942—375,000
Corporate bonds72,32242(3)72,361——72,361
Commercial paper18,462——18,462——18,462
Certificates of deposit1,500——1,500——1,500
Subtotal478,22642(3)478,26510,942—467,323
Total$1,721,546$12,234$(3)$1,733,777$1,201,147$27,213$505,417

As of December 31, 2025, we had $9.7 million of available-for-sale investments with unrealized losses, of which none have been in a continuous unrealized loss position for 12 months or longer. We do not intend to sell the investments and it is not more likely than not that we will be required to sell the investments before recovery of their amortized cost bases.

Note 4 – Inventory

Inventory consisted of the following at September 30, 2026 and December 31, 2025 (in thousands):

September 30, 2026December 31, 2025
Raw materials$273,597$152,680
Work-in-process12,2998,866
Finished goods293,329180,265
Total inventory$579,225$341,811

Note 5 – Goodwill and Intangible Assets

The changes in the carrying amount of goodwill for the nine months ended September 30, 2026 were as follows (in thousands):

Connected DevicesSoftware and ServicesTotal
Balance, beginning of period$51,249$1,318,940$1,370,189
Goodwill acquired4,581524,733529,314
Purchase accounting adjustments(23)(13,223)(13,246)
Foreign currency translation adjustments(170)(739)(909)
Balance, end of period$55,637$1,829,711$1,885,348

Intangible assets (other than goodwill) consisted of the following at September 30, 2026 and December 31, 2025 (in thousands):

September 30, 2026December 31, 2025
Useful LifeGross Carrying AmountAccumulated AmortizationNet Carrying AmountGross Carrying AmountAccumulated AmortizationNet Carrying Amount
Amortizable (definite-lived) intangible assets:
Developed technology3 ‑ 8 years$262,122$(73,940)$188,182$183,122$(44,399)$138,723
Customer relationships5 ‑ 10 years68,193(14,875)53,31841,329(8,960)32,369
Issued trademarks3 ‑ 23 years11,984(6,187)5,7979,900(3,856)6,044
Issued patents8 ‑ 26 years3,021(1,642)1,3793,017(1,602)1,415
Domain names5 ‑ 10 years5,022(3,120)1,9023,043(2,738)305
Total amortizable350,342(99,764)250,578240,411(61,555)178,856
Non-amortizable (indefinite-lived) intangible assets:
In-process research and development (1)16,600—16,60016,600—16,600
Trademarks1,068—1,0681,068—1,068
Patents and trademarks pending571—571448—448
Total non-amortizable18,239—18,23918,116—18,116
Total intangible assets$368,581$(99,764)$268,817$258,527$(61,555)$196,972

(1)During the nine months ended September 30, 2026, no in-process research and development costs were placed into service. During the nine months ended September 30, 2025, approximately $15.3 million had been placed into service.

Amortization expense of intangible assets for the three and nine months ended September 30, 2026 was $13.4 million and $38.4 million, respectively. Amortization expense of intangible assets for the three and nine months ended September 30, 2025 was $6.9 million and $20.2 million, respectively. Estimated amortization for intangible assets with definite lives for the remaining three months of 2026, the next five years ended December 31, and thereafter, is as follows (in thousands):

2026 remaining$13,445
202752,567
202850,334
202947,381
203035,772
203118,386
Thereafter32,693
Total$250,578

Note 6 – Strategic Investments

During the nine months ended September 30, 2026, we closed a series of transactions to acquire additional equity interests in an existing strategic investee for an aggregate amount of $191.8 million. We also recognized an unrealized gain on investments still held as of September 30, 2026 of $229.7 million related to observable price changes for existing investments in the same strategic investee. During the nine months ended September 30, 2026, we also acquired equity interests in a separate strategic investee for an aggregate amount of $49.9 million.

During the nine months ended September 30, 2025, we closed a series of transactions to acquire additional equity interests in an existing strategic investee for an aggregate amount of $215.1 million. We also recognized a gain of $167.4 million related to an observable price change of a separate existing strategic investee. Furthermore, we entered into a series of transactions to sell certain interests for cash consideration of $340.7 million in the same strategic investee, which was received during the nine months ended September 30, 2025. Previously unrealized gains of $320.8 million were realized from the collective sales, net of $1.3 million of transaction costs. Additionally, during the nine months ended September 30, 2025, a strategic investee completed a change-of-control transaction resulting in liquidation of the entity and distribution of consideration to its shareholders. In connection with the transaction, we received consideration of $36.9 million. We recognized a gain of $14.6 million from the sale, net of $0.1 million of transaction costs. Previously unrealized gains of $2.6 million were realized as a result of this sale.

The following table presents the carrying value of our strategic investments at September 30, 2026 and December 31, 2025 (in thousands):

September 30, 2026December 31, 2025
Equity securities:
Non-marketable equity securities (1)$918,922$416,236
Debt securities:
Non-marketable debt securities6,012597
Total strategic investments$924,934$416,833

(1)As of September 30, 2026 and December 31, 2025, the carrying value of our strategic investments held under the equity method of accounting was $29.3 million and $1.6 million, respectively.

The life to date cumulative upward and downward adjustments to the carrying value of our strategic equity investments accounted for under the ASC 321 measurement alternative and still held as of September 30, 2026 were $247.0 million and $15.4 million, respectively.

As of September 30, 2026 and December 31, 2025, the carrying value of our variable interest assets in unconsolidated non-public variable interest entities was $135.9 million and $9.4 million, respectively. These balances reflect the maximum exposure to loss, which is limited to the carrying value of the interest.

The following table summarizes the gains and losses associated with our strategic investments during the three and nine months ended September 30, 2026 and 2025 (in thousands):

Three Months Ended September 30,Nine Months Ended September 30,
2026202520262025
Realized gains (losses) recognized on strategic investments during the period, net$(11,517)$17,157$26,454$337,974
Reversal of prior period cumulative unrealized (gains) losses, net, for securities sold during the period(36,200)(2,585)—(161,820)
Unrealized gains on strategic investments still held at the reporting date (1)111,83446240,0696,536
Unrealized losses, including impairments, on strategic investments still held at the reporting date (1)——(97)(2,048)
Income from strategic investments, net$64,117$14,618$266,426$180,642

(1)Includes immaterial income (losses) from strategic investments held under the equity method of accounting, as well as immaterial unrealized gains (losses) for debt security strategic investments.

Note 7 – Accrued Liabilities

Accrued liabilities consisted of the following at September 30, 2026 and December 31, 2025 (in thousands):

September 30, 2026December 31, 2025
Accrued commissions$83,953$150,811
Accrued third-party product costs78,59773,497
Accrued cloud hosting fees32,68914,049
Accrued professional and IT fees30,69624,359
Accrued inventory in transit30,46815,728
Accrued salaries and benefits29,06035,251
Accrued income and other taxes27,60127,339
Accrued bonus14,90378,403
Accrued warranty expense10,18210,858
Accrued interest4,80631,855
Other accrued expenses55,52048,388
Total accrued liabilities$398,475$510,538

Note 8 – Debt

Notes payable, net, consisted of the following at September 30, 2026 and December 31, 2025 (in thousands):

September 30, 2026December 31, 2025
2030 Notes$1,000,000$1,000,000
2031 Notes1,150,000—
2033 Notes750,000750,000
2027 Notes—81,110
Total principal2,900,0001,831,110
Unamortized debt issuance costs(31,963)(20,388)
Total carrying amount of notes payable, net2,868,0371,810,722
Less: current portion (1)—(80,552)
Long-term notes payable, net$2,868,037$1,730,170

(1)During the nine months ended September 30, 2026, we redeemed and settled conversions in respect of all of our remaining outstanding 2027 Notes.

2031 Notes

In September 2026, we issued $1.15 billion aggregate principal amount of our 0% Convertible Senior Notes due 2031 (the “2031 Notes”) in a public offering registered under the Securities Act, of which the aggregate principal amount included the exercise in full of the underwriters’ option to purchase up to an additional $150.0 million principal amount.

The 2031 Notes mature on September 15, 2031, unless earlier converted, redeemed, or repurchased. The 2031 Notes will not bear regular cash interest and the principal amount of the notes will not accrete. The effective interest rate for the 2031 Notes is approximately 0.26%, which reflects amortization of debt issuance costs. The total combined gross proceeds from the issuance of the 2031 Notes were $1.15 billion. After deducting initial net underwriters’ discounts and commissions and other debt issuance costs of $14.7 million, the total combined net proceeds were approximately $1.14 billion, of which we used $114.9 million to pay the cost of the capped call transactions described below. The fair value of the 2031 Notes is determined based on the closing trading price of the respective notes payable as of the last day of trading for each period. We consider the fair value to be a Level 2 measurement, as the fair value is primarily affected by the trading price of our common stock and market interest rates.

Maturity DateConversion Price per ShareConversion Rate per $1,000 Par ValueNumber of Shares
2031 NotesSeptember 15, 2031$652.061.5336 shares1,763,640

Upon conversion, the terms of the 2031 Notes generally permit us to pay or deliver, as the case may be, cash, shares of our common stock, or a combination thereof, at our election. Any shares issued upon conversion shall be recorded in stockholders’ equity. The 2031 Notes are convertible, in multiples of $1,000 principal amount, at the option of the holders prior to the close of business on the business day immediately preceding June 15, 2031 only under the following circumstances:

  • during any calendar quarter commencing after the calendar quarter ending on December 31, 2026 (and only during such calendar quarter), if the last reported sale price of our common stock for at least 20 trading days (whether or not consecutive) during the 30 consecutive trading days ending on, and including, the last trading day of the immediately preceding calendar quarter is greater than or equal to 130% of the conversion price on each applicable trading day;

  • during the five business day period immediately after any ten consecutive trading day period (the “Measurement Period”), if the trading price per $1,000 principal amount of 2031 Notes for each trading day of the Measurement Period was less than 98% of the product of the last reported sale price per share of our common stock on such trading day and the conversion rate on such trading day;

  • upon the occurrence of certain corporate events (e.g., change in control or delisting of our common stock) or distributions on our common stock, as provided in the indenture governing the 2031 Notes; and

  • if we call the 2031 Notes for redemption at any time prior to the close of business on the second scheduled trading day immediately preceding the applicable redemption date, but only with respect to the 2031 Notes called (or deemed called) for redemption.

On or after June 15, 2031 until the close of business on the second scheduled trading day immediately preceding the maturity date of the 2031 Notes, holders of the 2031 Notes may convert all or any portion of their 2031 Notes at any time, regardless of the foregoing conditions. Upon conversion, the 2031 Notes will be settled in cash, shares of our common stock or a combination thereof, at our option, as described in the indenture governing the 2031 Notes.

If we undergo a fundamental change (as defined in the indenture governing the 2031 Notes), other than an exempted fundamental change, holders may require us to repurchase for cash all or any portion of their 2031 Notes at a price equal to 100% of the principal amount of the 2031 Notes to be repurchased, plus accrued and unpaid special interest, if any, up to but excluding the fundamental change repurchase date.

In addition, subject to certain conditions, holders may require us to repurchase their 2031 Notes on or around March 20, 2031 (the “Holder Repurchase Option”) at a repurchase price equal to the principal amount of the 2031 Notes to be repurchased, plus accrued and unpaid special interest, if any. We may elect to satisfy all or a portion of our obligation with respect to the principal amount of the repurchase price for the Holder Repurchase Option by issuing or delivering shares of our common stock, up to a specified maximum number of 2,875,000 shares (subject to customary anti-dilution and pro-rata adjustments) with the remainder, if any, of the repurchase price payable in cash, subject to and in accordance with the terms of the indenture governing the 2031 Notes.

Following certain corporate events or if we issue a notice of redemption, the conversion rate may be increased for holders who elect to convert their 2031 Notes in connection with such corporate event or during the relevant redemption period. Except in the case of a cleanup redemption, on or after September 20, 2029 and before the 31st scheduled trading day immediately before the maturity date, we may redeem for cash all or any portion of the 2031 Notes, at our option, if the last reported sale price of our common stock has been at least 130% of the conversion price then in effect for at least 20 trading days (whether or not consecutive) during any 30 consecutive trading day period ending on, and including, the trading day immediately preceding the date on which we provide notice of redemption, at a redemption price equal to 100% of the principal amount of the 2031 Notes to be redeemed, plus accrued and unpaid special interest, if any. We may also redeem for cash all, but not less than all, of the 2031 Notes at any time if the principal amount of 2031 Notes outstanding is less than 10% of the aggregate principal amount of 2031 Notes initially issued under the indenture (a “cleanup redemption”).

Interest expense related to the 2031 Notes was as follows (in thousands):

Three Months Ended September 30,Nine Months Ended September 30,
20262026
Contractual interest expense$—$—
Amortization of debt issuance costs9898
Total interest expense$98$98

2031 Capped Calls

To reduce the impact of potential economic dilution upon conversion of the 2031 Notes, in September 2026, we entered into privately negotiated capped call transactions (the “2031 Capped Calls”) with certain financial institutions (the “2031 Option Counterparties”) at a cost of $114.9 million, excluding approximately $0.1 million in related advisory expenses.

Purchase Price (in thousands)Shares Purchased
Capped Calls$114,8851,763,640

The 2031 Capped Calls cover 1,763,640 shares of our common stock, which corresponds to the number of shares initially underlying the 2031 Notes. The 2031 Capped Calls have an initial strike price of $652.06 per share, corresponding to the initial conversion price of the 2031 Notes, and an initial cap price of $1,049.94 per share, in each case subject to certain adjustments. The 2031 Capped Calls may also offset potential cash payments in excess of the principal amount of converted 2031 Notes, subject to the cap.

The 2031 Capped Calls may be settled in cash, shares of our common stock, or a combination thereof, generally consistent with our elected settlement method for the related 2031 Notes. The aggregate purchase price was recorded as a reduction to additional paid-in capital. The 2031 Capped Calls are separate from the 2031 Notes, expire upon the maturity of the 2031 Notes, and do not provide any rights to holders of the 2031 Notes. The 2031 Capped Calls are intended to reduce potential economic dilution associated with the 2031 Notes but do not offset their dilutive effect for purposes of calculating diluted income per common share. As of September 30, 2026, all 1,763,640 shares remained subject to the 2031 Capped Calls.

2030 and 2033 Notes

In March 2025, we issued $1.0 billion aggregate principal amount of 6.125% Senior Notes due 2030 (the “2030 Notes”) and $750.0 million aggregate principal amount of 6.250% Senior Notes due 2033 (the “2033 Notes” and, together with the 2030 Notes, the “Senior Notes”) in a private offering. Interest expense related to the Senior Notes was as follows (in thousands):

Three Months Ended September 30,Nine Months Ended September 30,
2026202520262025
Contractual interest expense$27,031$27,031$81,094$60,069
Amortization of debt issuance costs8447912,4911,741
Total interest expense$27,875$27,822$83,585$61,810

2027 Notes

In December 2022, we issued $690.0 million aggregate principal amount of our 0.50% Convertible Senior Notes due 2027 (the “2027 Notes”) in a private offering. During the year ended December 31, 2025, we entered into and closed separate, privately negotiated exchange agreements with certain holders of the 2027 Notes to exchange $604.3 million aggregate principal amount of the 2027 Notes for consideration consisting of cash and shares of our common stock. We had $81.1 million aggregate principal amount of 2027 Notes outstanding as of December 31, 2025.

In December 2025, we delivered a notice of redemption to redeem all of our outstanding 2027 Notes in February 2026 at a redemption price equal to 100% of the principal amount of the notes to be redeemed, together with accrued and unpaid interest. Holders of the 2027 Notes were able to convert their notes prior to the redemption date for cash up to the principal amount of any notes being converted and shares of our common stock for any conversion obligation in excess of the principal amount. We redeemed $0.8 million aggregate principal amount of the 2027 Notes on February 10, 2026, and we settled conversions in respect of $80.3 million aggregate principal amount of the 2027 Notes on February 11, 2026, with $80.3 million in cash and 211,870 shares of our common stock. We also received 41,139 shares from option counterparties in connection with partial termination of the Note Hedge and Warrants in February 2026, as discussed further below. As a result, we have no 2027 Notes outstanding following settlement of the aforementioned redemption as of September 30, 2026. Interest expense related to the 2027 Notes was as follows (in thousands):

Three Months Ended September 30,Nine Months Ended September 30,
2026202520262025
Contractual interest expense$—$354$44$1,487
Amortization of debt issuance costs—3325581,411
Total interest expense$—$686$602$2,898

Fair Value of Debt

The estimated fair value of our outstanding debt at September 30, 2026 and December 31, 2025 is as follows (in thousands):

September 30, 2026December 31, 2025
2030 Notes$991,250$1,036,830
2031 Notes1,138,420—
2033 Notes735,525779,768
2027 Notes—203,956

2027 Convertible Note Hedge

To reduce the impact of potential economic dilution upon conversion of the 2027 Notes, in December 2022, we entered into a convertible note hedge transaction (the “Note Hedge” or “2027 Note Hedge”) with certain investment banks (the “2027 Option Counterparties”), with respect to our common stock, concurrently with the issuance of the 2027 Notes.

Purchase Price (in thousands)Shares Purchased
2027 Note Hedge$194,9943,016,680

The Note Hedge covers shares of our common stock at a strike price per share that corresponds to the initial conversion price of the respective 2027 Notes, subject to adjustment. As of September 30, 2026, 2,642,030 shares remain covered by the Note Hedge, which is subject to automatic exercise at expiration on December 15, 2027, unless earlier terminated.

2027 Convertible Note Warrants

Proceeds (in thousands)Initial SharesStrike PriceFirst Expiration
2027 Warrants$124,2693,016,680$338.86March 15, 2028

In December 2022, we entered into warrant transactions with certain investment banks, whereby we sold Warrants to acquire, subject to adjustment, the number of shares of our common stock shown in the table above. If the average market value per share of our common stock exceeds the strike price of the Warrants, such Warrants can have a dilutive effect on our earnings per share to the extent we report net income. According to the terms of the Warrants, the Warrants will be automatically exercised over a 60-trading day period beginning on the first expiration date as set forth above, unless earlier terminated. As of September 30, 2026, 2,662,063 shares remain subject to the Warrants.

Line of Credit

Our credit agreement provides for a senior unsecured multi-currency revolving credit facility (the “Credit Agreement”) which previously included a total aggregate principal amount of $300.0 million (with an accordion feature which allowed for an increase in the total line of credit up to $400.0 million), as well as availability for the issuance of letters of credit of $50.0 million.

In September 2026, in connection with the issuance of the 2031 Notes, we entered into a second amendment to the Credit Agreement. The amendment increases the existing revolving credit facility by $200.0 million to a total aggregate principal amount of $500.0 million and permits us to request an increase in the facility by an additional $150.0 million. The amendment extends the maturity date of the Credit Agreement from March 11, 2030 to the earliest of: (i) the fifth anniversary of the amendment’s closing (September 18, 2031), (ii) 91 days prior to the stated maturity of the 2031 Notes (unless fully redeemed, repurchased, converted, or defeased, with qualifying refinancing), (iii) 91 days prior to March 20, 2031 (the 2031 Notes’ optional repurchase date) if certain share-settlement notice and stock-price conditions are met, or (iv) 91 days prior to the maturity of any other permitted convertible indebtedness (subject to similar conditions).

As of September 30, 2026, no amounts were drawn under the Credit Agreement. Under the terms of the line of credit, available borrowings are reduced by outstanding letters of credit. As of September 30, 2026, we had letters of credit outstanding of approximately $9.1 million under the facility and available borrowing of $490.9 million, excluding amounts available under the accordion feature. As of September 30, 2026, we are in compliance with the associated covenants under the Credit Agreement.

Note 9 – Income Taxes

Effective Tax Rate

The overall effective tax rate for the three months ended September 30, 2026 was 27.8%. This rate differs from the federal statutory rate due to state income taxes and increases in tax reserves, partially offset by a net tax benefit from stock-based compensation and R&D tax credits. The effective tax rate was favorably impacted by a $3.3 million net tax benefit from stock-based compensation for stock awards that vested during the three months ended September 30, 2026.

By comparison, our overall effective tax rate for the three months ended September 30, 2025 was 113.9%. This rate differed from the federal statutory rate due to lower pre-tax book income in that period, which magnified the relative impact of permanent and discrete items, including the impact of changes in tax law on our R&D tax credit. The effective tax rate was favorably impacted by a $15.4 million net tax benefit from stock-based compensation for stock awards that vested during the three months ended September 30, 2025.

The overall effective tax rate for the nine months ended September 30, 2026 was 18.0%. This rate differs from the federal statutory rate due to the favorable impact of R&D tax credits, a net tax benefit from stock-based compensation, and a gain on an investment transaction not recognized for tax, partially offset by increases in tax reserves and state income taxes. The effective tax rate was favorably impacted by a $26.4 million net tax benefit from stock-based compensation for stock awards that vested during the nine months ended September 30, 2026.

By comparison, our overall effective tax rate for the nine months ended September 30, 2025 was (43.1)%. This rate differed from the federal statutory rate due to the net favorable impacts of stock-based compensation and R&D tax credits, partially offset by an increase in uncertain tax positions. The effective tax rate was favorably impacted by an $84.2 million net tax benefit from stock-based compensation for stock awards that vested during the nine months ended September 30, 2025.

Note 10 – Stockholders’ Equity

Our stock-based compensation program includes grants of service-based restricted stock units (“RSUs”), performance-based restricted stock units (“PSUs”), and performance-based stock options (“stock options”) under the Axon Enterprise, Inc. Amended and Restated 2022 Stock Incentive Plan (the “Amended 2022 Plan”) and grants of eXponential stock units (“XSUs”) under the Axon Enterprise, Inc. Employee eXponential Stock Plan (the “Employee XSP”) and the CEO Performance Award. With the exception of the Employee XSP as discussed further below, there were no significant changes to our RSUs, PSUs and stock options during the nine months ended September 30, 2026.

Employee XSP and CEO Performance Award

The Employee XSP includes an approved pool of approximately 4.5 million shares of common stock reserved for grants of XSUs to employees. Approximately 0.8 million XSUs remain available to grant to employees under this program as of September 30, 2026. A total of approximately 0.7 million XSUs were granted during the nine months ended September 30, 2026. Shareholders previously approved a grant of 679,102 XSUs for the CEO Performance Award on May 10, 2024.

On January 23, 2026, the Compensation Committee of the Board of Directors approved the addition of two incremental tranches to the Employee XSP. Consistent with prior tranches, Tranches 8 and 9 are performance-based and contingent upon achievement of stock price goals, operational goals, and minimum service requirements. These three independent vesting conditions are described in the following table:

Operational Goals (1) (in millions)Stock Price GoalMinimum Service Requirement
Tranche (2)RevenueAdj. EBITDAEmployee XSPCEO Performance AwardGoal Expiration
1$1,834or$382and$247.40andJune 2025December 2028December 31, 2026
22,293or497and309.25andDecember 2025December 2028December 31, 2027
32,866or611and386.56andJune 2026December 2029December 31, 2028
43,583or792and483.20andDecember 2026December 2029December 31, 2029
54,479or1,027and604.00andJune 2027December 2030December 31, 2030
65,599or1,339and755.00andDecember 2027December 2030December 31, 2031
76,999or1,689and943.75andJune 2028December 2030December 31, 2032
88,758or2,127and1,179.69andDecember 2029—December 31, 2033
910,945or2,673and1,474.61andJune 2031—December 31, 2034

(1) Operational goals are measured, as of any date, for the previous four consecutive fiscal quarters, beginning with the Company’s first full fiscal quarter ending after the fiscal quarter in which the grant date occurred. In connection with certain acquisitions which were completed in the first quarter of 2026, the operational goals were adjusted as required by the terms of the Employee XSP and CEO Performance Award grant agreements for the respective tranches.

(2) Tranches 1, 2, and 3 vested in June 2025, December 2025, and June 2026, respectively. As of September 30, 2026, for certain grantees, the shares acquired upon vesting of Tranche 3 remain subject to a holding period requirement under the plan, which will expire on the earlier of (i) December 31, 2030 and (ii) the date on which the subsequent tranche vests.

Stock-based Compensation Expense

The following table summarizes the composition of stock-based compensation expense for the three and nine months ended September 30, 2026 and 2025 (in thousands):

Three Months Ended September 30,Nine Months Ended September 30,
2026202520262025
Cost of product and service sales$12,960$12,703$35,010$38,151
Selling, general and administrative expenses78,23375,072215,740218,606
Research and development expenses65,17258,377184,312168,878
Total stock-based compensation expense (1)$156,365$146,152$435,062$425,635

(1)For the nine months ended September 30, 2026, stock-based compensation expense included $5.7 million in non-recurring costs, the majority of which derived from ongoing acquisition integration activities.

At-the-Market Equity Offering

We participate in an “at-the-market” equity offering program (the “ATM”), pursuant to which we are authorized to sell up to a total of approximately 2.0 million shares of our common stock.

During the nine months ended September 30, 2026, we sold approximately 0.2 million shares of our common stock under the ATM. We generated approximately $101.2 million in aggregate gross proceeds from sales under the ATM. We recorded aggregate net proceeds of $100.3 million in additional paid-in capital after deducting related expenses, including commissions to the sales agent and issuance costs of $0.9 million.

As of September 30, 2026, there were approximately 1.0 million shares remaining. We utilize the net proceeds from this offering program for general corporate purposes, which may include providing capital to satisfy a portion of the tax obligations related to the vesting and settlement of stock compensation awards granted to our employees under our stock plans and funding ongoing strategic investments and acquisitions as we continue to expand our product ecosystem.

Stock Incentive Plan

In May 2024, our shareholders approved the Amended 2022 Plan authorizing an additional 2.2 million shares, plus remaining available shares under prior plans, for issuance under the Amended 2022 Plan. Combined with the shares of our common stock available under our legacy stock incentive plans, there are 2.4 million shares of our common stock available for grant under the Amended 2022 Plan as of September 30, 2026.

Note 11 – Commitments and Contingencies

Product Litigation

As a manufacturer of weapons and other law enforcement tools used in high-risk field environments, we have historically been the subject of product liability litigation concerning the use of our products. Currently, we are named as a defendant in only one such lawsuit regarding the use of a TASER CED by law enforcement in connection with an arrest.

We continue to aggressively defend all product litigation, which we do not believe will have a material effect on our financial position, results of operations or cash flows. We are self-insured for the first $5.0 million of any product claim. No judgment or settlement has ever exceeded this amount in any product liability case to which we have been a party.

Other Matters

Pending in the District of New Jersey (Case No. 3:23-cv-7182) is a putative antitrust class action brought by three municipalities based largely on the Federal Trade Commission’s dismissed administrative complaint concerning Axon’s 2018 acquisition of insolvent body camera competitor, Vievu LLC. We deny all allegations of anticompetitive or other misconduct and are vigorously defending the case.

Pending in the Eastern District of Virginia (Case No. 1:24-CV-01625) is a patent infringement suit filed by Airspace Systems, Inc. (“Airspace”) against Dedrone and Axon involving certain drone technology. The case has been stayed pending Axon’s invalidity challenges to all three asserted patents in the United States Patent and Trademark Office, which instituted review last fall. On October 7, 2026, the Patent Trial and Appeal Board cancelled two of the patents in their entirety and invalidated all but two claims in the third patent. The litigation is expected to remain stayed during the appellate process. Separately, pending in the Western District of Texas (Case No. 1:24-cv-1497) is a patent infringement suit filed by CentralSquare Technologies LLC (“CST”) against Carbyne, Inc. and Carbyne Ltd. (jointly “Carbyne”) relating to 911 technology. CST seeks injunctive relief and damages in an unspecified amount. Carbyne, which we acquired on February 18, 2026, denies infringement and has countersued CST for infringement of its own patent. No trial date has been set.

Pending in the Northern District of California (Case No. 3:26-cv-11183) and in Riverside County (CA) Superior Court (Case No. CVRI26O6719) are putative class actions seeking statutory damages and injunctive relief for alleged violations of California’s Automated License Plate Reader (“ALPR”) disclosure statute. We deny all allegations, including the statute’s applicability to Axon, and will vigorously defend these cases. We are also aware of a third ALPR complaint recently filed in the Northern District, but we have not yet been served. These cases will likely be consolidated.

General

From time to time, we are notified that we may be a party to a lawsuit or that a claim is being made against us. After carefully assessing the claim, and assuming we determine that we are not at fault or we disagree with the damages or relief demanded, we vigorously defend any lawsuit filed against us. We record a liability when losses are deemed probable and reasonably estimable. When losses are deemed reasonably possible but not probable, we determine whether it is possible to provide an estimate of the amount of the loss or range of possible losses for the claim, if material for disclosure. In evaluating matters for accrual and disclosure purposes, we take into consideration factors such as our historical experience with matters of a similar nature, the specific facts and circumstances asserted, the likelihood of our prevailing, the availability of insurance, and the severity of any potential loss. We reevaluate and update accruals as matters progress over time.

Based on our assessment of outstanding litigation and claims as of September 30, 2026, we have determined that it is not reasonably possible that these losses, if any, from lawsuits will individually, or in the aggregate, materially affect our results of operations, financial condition or cash flows. However, the outcome of any litigation is inherently uncertain and there can be no assurance that any expense, liability or damages that may ultimately result from the resolution of these matters will be covered by our insurance or will not be in excess of amounts recognized or provided by insurance coverage and will not have a material adverse effect on our operating results, financial condition or cash flows.

Off-Balance Sheet Arrangements

Under certain circumstances, we use letters of credit and surety bonds to guarantee our performance under various contracts, principally in connection with the installation and integration of Axon cameras and related technologies. Certain of our letters of credit and surety bonds have stated expiration dates with others being released as the contractual performance terms are completed. At September 30, 2026, we had outstanding letters of credit issued under our credit facility of $9.1 million that are expected to expire through 2029. We also had outstanding letters of credit of $0.6 million that do not draw against our credit facility. Additionally, we had $7.3 million of outstanding surety bonds as of September 30, 2026, with expiration dates ranging through 2029.

Note 12 – Accumulated Other Comprehensive Income (Loss)

The following tables reflect the changes in accumulated other comprehensive income (loss), net of tax (in thousands):

Unrealized (Losses) Gains on Available-for-Sale Investments (1)Foreign Currency TranslationTotal
Balance, December 31, 2025$83$(11,889)$(11,806)
Other comprehensive income (loss)(111)647536
Balance, March 31, 2026(28)(11,242)(11,270)
Other comprehensive loss—(5,147)(5,147)
Balance, June 30, 2026(28)(16,389)(16,417)
Other comprehensive income (loss)(36)2,2612,225
Balance, September 30, 2026$(64)$(14,128)$(14,192)

(1)Amounts are net of immaterial tax impacts.

Unrealized (Losses) Gains on Available-for-Sale Investments (1)Foreign Currency TranslationTotal
Balance, December 31, 2024$(30)$(18,154)$(18,184)
Other comprehensive income (loss)(124)358234
Balance, March 31, 2025(154)(17,796)(17,950)
Other comprehensive income735,1595,232
Balance, June 30, 2025(81)(12,637)(12,718)
Other comprehensive income (loss)213(25)188
Balance, September 30, 2025$132$(12,662)$(12,530)

(1)Amounts are net of immaterial tax impacts.

Note 13 – Segment Data

Information relative to our reportable segments was as follows (in thousands):

Three Months Ended September 30,
20262025
Connected DevicesSoftware and ServicesTotalConnected DevicesSoftware and ServicesTotal
Net sales$471,524$437,030$908,554$405,399$305,242$710,641
Cost of sales(268,629)(124,947)(393,576)(203,173)(80,120)(283,293)
Other segment items (1)7,58015,68223,2628,9029,20018,102
Adjusted gross margin$210,475$327,765$538,240$211,128$234,322$445,450
Other segment items (1)(23,262)(18,102)
Selling, general and administrative(280,496)(252,803)
Research and development(192,402)(176,674)
Interest income5,65723,941
Interest expense(28,337)(28,912)
Other income, net59,52022,803
Income before provision for income taxes$78,920$15,703

(1) Other segment items includes adjustments for noncash stock-based compensation expense and amortization of acquired intangible assets to arrive at the profit measure used by the CODM.

Nine Months Ended September 30,
20262025
Connected DevicesSoftware and ServicesTotalConnected DevicesSoftware and ServicesTotal
Net sales$1,430,898$1,189,390$2,620,288$1,122,655$860,157$1,982,812
Cost of sales(744,646)(336,931)(1,081,577)(566,861)(219,121)(785,982)
Other segment items (1)22,87742,69665,57327,87227,92255,794
Adjusted gross margin$709,129$895,155$1,604,284$583,666$668,958$1,252,624
Other segment items (1)(65,573)(55,794)
Selling, general and administrative(830,571)(718,524)
Research and development(590,039)(490,264)
Interest income23,08357,798
Interest expense(85,081)(65,419)
Other income, net255,722104,790
Income before provision for income taxes$311,825$85,211

(1) Other segment items includes the adjustment for noncash stock-based compensation expense, amortization of acquired intangible assets, compensation taxes related to Employee XSP vesting, non-recurring severance costs, and inventory step-up amortization related to acquisitions to arrive at the profit measure used by the CODM.

The following table presents supplemental information included within the measure of profit or loss, adjusted gross margin, reviewed by our CODM (in thousands). There are no other material items presented to our CODM by segment or included within adjusted gross margin for supplemental disclosure.

Three Months Ended September 30,
20262025
Connected DevicesSoftware and ServicesTotalConnected DevicesSoftware and ServicesTotal
Depreciation and amortization$12,488$9,188$21,676$9,188$4,324$13,512
Significant noncash items:
Stock-based compensation expense5,8507,11012,9607,5845,11912,703
Warranty reserve expense3,333—3,3332,584—2,584
Provisions for inventory1,893—1,8931,737—1,737
Nine Months Ended September 30,
20262025
Connected DevicesSoftware and ServicesTotalConnected DevicesSoftware and ServicesTotal
Depreciation and amortization$36,683$26,240$62,923$26,783$12,381$39,164
Significant noncash items:
Stock-based compensation expense (1)17,14117,66334,80422,64315,50838,151
Warranty reserve expense10,188—10,1889,378—9,378
Provisions for inventory2,607—2,6073,578—3,578

(1) For the nine months ended September 30, 2026, stock-based compensation expense excludes immaterial severance costs recorded to cost of product and service sales.

Note 14 – Business Combinations

The consolidated financial statements include the operating results from each acquisition from the date of acquisition noted below. Supplemental pro forma information has not been presented as the effects of the business combinations during the three and nine months ended September 30, 2026 were not material to our consolidated financial statements.

2026 Business Combinations

Carbyne

On February 18, 2026, we acquired the remaining 89.3% interest in Carbyne Ltd. (“Carbyne”), a leading cloud-native emergency communications and response platform. Net of cash acquired and equity consideration attributable to pre-combination service, total cash paid in the business combination was approximately $551.7 million. Incremental consideration transferred was approximately $563.2 million. The acquisition aligns with our mission and positions us to accelerate next-generation public safety communications and emergency response solutions. We recorded acquisition-related transaction and integration costs of $8.0 million and $17.0 million during the three and nine months ended September 30, 2026, respectively. Our existing interest of approximately 10.7% had a fair value at the acquisition date of $67.5 million, which resulted in a non-taxable gain of $38.0 million.

The purchase price allocation is subject to revision during the measurement period for purchase accounting adjustments to balances such as intangible assets, pre-acquisition legal contingencies, working capital, and income tax assets and liabilities, and is expected to be completed by the first quarter of 2027. During the three and nine months ended September 30, 2026, we recorded immaterial measurement period adjustments. Based on the current purchase price allocation, including measurement period adjustments, we have recorded $523.3 million of goodwill, $108.2 million of identifiable intangible assets, $10.1 million of acquired cash, $2.2 million of net deferred tax liabilities, and assumed $8.7 million of other net liabilities.

As of the acquisition date, the identifiable intangible assets included $79.0 million of developed technology, $27.1 million of customer relationships, and $2.1 million of trademarks. The fair values of the intangible assets were calculated using the multi-period excess earnings method for the developed technology, the distributor method for customer relationships, and the relief-from-royalty method for the trademarks. The significant assumptions used to estimate the fair value of the developed technology included projected revenues, estimated economic life of 8 years, and an appropriate discount rate. The significant assumptions used to estimate the fair value of the customer relationships included projected revenues, customer attrition rates, distributor margins, and appropriate discount rates. The weighted average amortization period of the acquired intangible assets as of the acquisition date was 7.9 years.

The goodwill associated with this business combination is primarily attributable to synergies that are expected to be achieved from the integration of the business and is not deductible for tax purposes. Consistent with the assignment of goodwill, the consolidated results of Carbyne are included in our Software and Services reportable segment following the business combination.

2025 Business Combinations

Prepared

On October 1, 2025, we acquired the remaining 99.2% interest in Invictus Apps, Inc. (“Prepared”), a leading provider of AI-powered emergency communications software. Net of cash acquired and equity consideration attributable to pre-combination service, total cash paid in the business combination was $623.9 million. Incremental consideration transferred was $728.1 million. The acquisition aligns with our mission and positions us to accelerate next-generation public safety communications and emergency response solutions. Acquisition-related transaction and integration costs were immaterial for the three and nine months ended September 30, 2026. Our existing interest of approximately 0.8% had a fair value at the acquisition date of $6.2 million, which resulted in a non-taxable gain of $2.2 million.

The purchase price allocation was subject to revision during the measurement period through September 30, 2026. During the nine months ended September 30, 2026, we recorded various measurement period adjustments, primarily consisting of adjustments to deferred tax assets, resulting in an $11.8 million decrease to goodwill. Based on the final purchase price allocation, including measurement period adjustments, we have recorded $585.0 million of goodwill, $98.9 million of acquired cash, $47.5 million of identifiable intangible assets, a $3.8 million net deferred tax asset, and assumed $1.0 million of other net liabilities.

As of the acquisition date, the identifiable intangible assets included $37.0 million of developed technology, $7.3 million of customer relationships, and $3.2 million of trademarks. The fair values of the intangible assets were calculated using the relief-from-royalty method for the developed technology, the multi-period excess earnings method for customer relationships, and the relief-from-royalty method for the trademarks. The significant assumptions used to estimate the fair value of the developed technology included projected revenues, the selected royalty rate, estimated economic life of 5 years, and an appropriate discount rate. The weighted average amortization period of the acquired intangible assets as of the acquisition date was 5 years.

The goodwill associated with this business combination is primarily attributable to synergies that are expected to be achieved from the integration of the business and is not deductible for tax purposes. Consistent with the assignment of goodwill, the consolidated results of Prepared are included in our Software and Services reportable segment following the business combination.

Note 15 – Subsequent Event

On November 5, 2026, the Company entered into agreements for incremental non-voting minority investments of up to $1.2 billion in Skydio, Inc. (“Skydio”), a privately-owned autonomous drone manufacturer, which are expected to increase the Company’s ownership from 15% to approximately 37% on a fully diluted basis. The Company expects the investments to be settled with up to approximately $720.0 million in cash and the remainder in shares of the Company’s common stock, with the final mix subject to the results of a tender offer and secondary purchases that are expected to close in the fourth quarter of 2026 and first quarter of 2027. The number of shares of the Company’s common stock issued shall be determined utilizing the volume-weighted average price per share of the Company’s common stock, as reported on the NASDAQ Global Select Market, for the 10-trading day period up to and including the trading day immediately preceding two business days prior to settlement.

The Company’s primary investment in Skydio, with an aggregate purchase price of approximately $254.9 million, payable 50% in cash and 50% in shares of the Company’s common stock, closed on November 5, 2026, resulting in a cash payment of approximately $127.5 million and a commitment to deliver approximately $127.5 million of the Company’s common stock. The remaining investments, consisting of a tender offer and secondary purchases, are valued at up to approximately $968.6 million in aggregate and are expected to close through a series of transactions during the fourth quarter of 2026 and first quarter of 2027. The incremental investments will be included in non-marketable equity investments and accounted for under the measurement alternative method, as we do not have significant influence over Skydio’s operations.

Previous: Cover and table of contents · Next: Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations